Trial intelligence / Profile preview

Foscan PDT for Bile Duct Carcinoma

NCT01016002Phase 2Unknown

Sponsor
University of Salzburg
Start
Jan 2006
Primary completion
Dec 2011
Modality
Light/Condition-Responsive Prodrugs
Countries
2
01

Overview

A Phase 2 trial of temoporfin in cholangiocarcinoma, sponsored by University of Salzburg. Status: unknown.

02

Drugs

temoporfin
03

Conditions

cholangiocarcinoma

Beyond the preview

Go deeper on NCT01016002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01016002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call